Dyadic International
DYAI • NASDAQ
Dyadic International is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark A. Emalfarb, with a market cap of $24.7M.
CEOMark A. Emalfarb
Next Earnings
Upcoming earnings announcement for Dyadic International
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.02
Revenue Estimate
$1.1M
Earnings History
Past 12 earnings reports for Dyadic International
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.06Est: -$0.04 | -50.0% | $565.5KEst: $1.4M | -59.8% | — |
| Nov 12, 2025 | Q3 2025 | -$0.06Est: -$0.04 | -50.0% | $1.2MEst: $1.2M | +0.3% |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.06Est: -$0.06 | 0.0% | $966.6KEst: $600.0K | +61.1% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.07 | — | $393.6K | — | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$0.05Est: -$0.04 | -25.0% | $816.5KEst: $1.6M | -49.0% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.01Est: -$0.07 | +85.7% | $2.0MEst: $1.1M | +78.0% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.07Est: -$0.06 | -16.7% | $385.9KEst: $1.0M | -61.4% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.07 | — | $334.6K | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.08Est: -$0.06 | -33.3% | $686.5KEst: $800.0K | -14.2% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.06Est: -$0.07 | +14.3% | $397.1KEst: $800.0K | -50.4% | — |
| Aug 9, 2023 | Q2 2023 | -$0.07Est: -$0.05 | -40.0% | $837.2KEst: $1.3M | -35.6% | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.03 | — | $978.1K | — | 10-Q |